Glaucoma is a leading cause worldwide of blindness and visual impairment. Transforming growth factor-␤2 (TGF␤2) has been implicated in the pathogenesis of primary open-angle glaucoma (POAG) based on elevated levels in glaucomatous aqueous humor and its ability to induce extracellular matrix (ECM) remodeling in the trabecular meshwork (TM). The goal of this study was to generate a rodent model of POAG using viral gene transfer of human TGF␤2.
G laucoma is a leading cause of visual impairment and blindness, affecting approximately 60 million persons worldwide. 1 Elevated intraocular pressure (IOP) is a causative risk factor for both the development and the progression of primary open angle glaucoma (POAG). [2] [3] [4] [5] The exact mechanism in the pathogenesis of glaucoma is yet to be fully elucidated. However, pathologic changes in the aqueous humor outflow pathway, particularly the trabecular meshwork (TM), are related to increased outflow resistance and elevated IOP. These changes include abnormal accumulation of extracellular matrix (ECM), 6 -9 abnormal cytoskeletal changes in the TM cells, 10, 11 and in MYOC glaucoma, stress of TM cells associated with mutant myocilin-induced protein misfolding and abnormal catabolism. [12] [13] [14] [15] [16] [17] In addition, transforming growth factor ␤ (TGF␤) may play an important role in the development of glaucoma. Of the three isoforms of TGF␤ (TGF␤1, TGF␤2, TGF␤3), TGF␤2 has been most widely studied in glaucoma. Elevated levels of TGF␤2 in the aqueous humor (AH) of glaucoma patients have been associated with glaucoma pathogenesis. 18 -26 TGF␤2 is expressed by TM cells and can affect many TM cell functions, including inducing ECM remodeling and overexpression in ocular tissues, 27, 28 inhibiting TM cell proliferation, 29 and increasing TM cell phagocytosis. 30 TGF␤2 perfusion in human anterior eye segments increases IOP and ECM deposition in the AH drainage structure, 28, 31, 32 supporting the causative role of TGF␤2 in this aspect of glaucoma pathogenesis. Despite these important findings implicating the involvement of TGF␤2 in glaucoma, the effect of this cytokine on IOP in animals has not been demonstrated.
To evaluate the role of TGF␤2 in glaucoma pathogenesis and to develop in vivo models of glaucoma, we sought to express TGF␤2 at sustained pathophysiological levels in the anterior segment of the rodent eye by viral vector transduction. Viral vectors have been shown to transduce cells of the AH outflow pathway and to result in expression of the delivered transgene. 33, 34 Adenoviral vectors delivered intracamerally or intravitreally readily infect the TM, iris, ciliary body, and corneal endothelium of rodents. 16 TGF␤2 is produced in the cell as a latent 390-amino acid precursor that forms dimers through association of its latencyassociated peptide (LAP). 35 Dimeric, mature, biologically active C-terminal 112-amino acid TGF␤2 is generated from the cleavage and dissociation of LAP. Removal of LAP can be readily achieved in vitro by treatment of the protein with acid, heat, or chaotropic agents. In vivo removal of LAP occurs primarily through the protease furin, which is regulated by Emelin-1. 36 Our first attempt at adenoviral overexpression of wild-type, latent TGF␤2 in rat eyes resulted in no IOP change, suggesting little in situ activation. Based on bioactivating mutations introduced into the LAP-binding portion of the orthologous monkey TGF␤1, 37 pig TGF␤1, 38 human TGF␤1, 39 cow TGF␤1, 40 rat TGF␤1, 41 mouse TGF␤1, 42 and mouse TGF␤2, 42 we introduced similar mutations into human TGF␤2 to generate spontaneously active human TGF␤2 (Fig. 1) . In vitro and in vivo characterization of the viral vector encoding this mutant TGF␤2 demonstrated the production of spontaneously active TGF␤2 with biological activity, including marker gene upregulation, ocular hypertension in rats and mice, and reduced AH outflow facility in the mouse. Our findings suggest that virusexpressed human mutant TGF␤2 may be useful for evaluation of the pathophysiological activities of TGF␤2 in the eye and for the development of an animal model that mimics the major risk factors of elevated IOP and decreased aqueous outflow facility of glaucoma in humans.
METHODS

Rodents
All animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and all protocols were approved and monitored by the Animal Care and Use Committee of Alcon Research, Ltd. BALB/cJ mice (2-5 months old; Jackson Laboratory, Bar Harbor, ME) and Wistar rats (2-4 months old; Charles River Laboratories, Wilmington, MA) used in this study were housed and handled as previously described. 43 The animals were maintained on a 12-hour light/12-hour dark cycle (lights on 6:00 a.m.). Food and water were available ad libitum.
Recombinant Plasmid and Adenoviral Vectors
Wild-type (WT) human TGF␤2 cDNA (NM_003238) was obtained from Origene (Rockville, MD) in the pCMV6-XL5 vector. To produce cDNA coding for the active human TGF␤2, coding sequences for the cysteines at positions 226 and 228 were converted to serines (Cell & Molecular Technologies, Inc., Phillipsburg, NJ). The region extending from the HindIII site (nt 1976) to the PpuMI site (nt 2395) was synthesized such that nucleotides 1985 and 1991 were changed from G to C, converting the cysteines to serines at amino acids 226 and 228 of the hTGF␤2 protein. This fragment was cloned into pCMV6-XL5.hTGF␤2. The WT and mutant coding region cDNAs were then subcloned into the pacAd5.CMV.KN.pA shuttle vector (Source: University of Iowa, Gene Transfer Vector Core) using EcoRI/Xba1 restriction. Viruses were purified by CsCl gradient centrifugation and dialyzed against TE (Tris-EDTA) buffer containing 10% sucrose and stored at Ϫ80°C (University of Iowa, Gene Transfer Vector Core). Each virus was tested for WT revertants and for titer by PCR and A549 plaque assay, as described. 44 Empty adenovirus (Ad.Empty) was used as a negative control.
Cell Culture
Human GTM3 cells were cultured as previously described. 45 Chinese hamster ovary (CHO) cells were maintained in F12K medium (Invitrogen, Carlsbad, CA). The medium was supplemented with 10% FBS (Hyclone, Logan, UT), 100 U/mL penicillin G, 100 g/mL streptomycin sulfate, 2 mM L-glutamine (Invitrogen), and all cells were incubated in a humidified 5% CO 2 atmosphere at 37°C. Adenoviral transductions were performed essentially as described.
14,16 CHO cells were transiently transfected with plasmids using reagent as instructed by the manufacturer (Lipofectamine 2000; Invitrogen). and given a single intravitreal or intracameral injection of a suspension of adenovirus of a specified titer in a volume of 5 L for the rat eye and 2 L for the mouse eye. Ocular injections were administered using a Hamilton (Reno, NV) glass microsyringe fitted with a custom-made 1-inch, 33-gauge needle with a 10°bevel, as described previously, 16 while the uninjected contralateral eye served as a control. Each injection was made over the course of approximately 30 seconds The needle was then left in place in the anterior chamber or vitreous for a another minute before being rapidly withdrawn. IOP measurements were taken in conscious rats and mice using the rebound tonometer (TonoLab; Tiolat Oy; Helsinki, Finland), as described. 43 The IOP investigator was masked to the identity of the injected adenovirus and to which eye was injected.
Adenovirus Injections and IOP Measurements
Tissue Collection and RNA Isolation
At specified time points after adenoviral vector delivery, animals were euthanatized with CO 2 asphyxiation. Eyes were enucleated and bisected into anterior and posterior sections, and each section was placed in a separate microfuge tube containing 1 mL reagent (Trizol; Invitrogen), 1 L glycogen covalently linked with blue dye (GlycoBlue; Ambion, Foster City, CA), and one 5-mm stainless steel ball (Qiagen, Valencia, CA). Samples were homogenized for 5 minutes at 25 Hz (TissueLyser system; Qiagen) and processed according to the reagent manufacturer's recommended procedure (Invitrogen). RNA was dissolved in 10 L nuclease-free H 2 O, and the concentration was determined by absorbance (A260).
First-Strand cDNA Preparation
Contaminating adenoviral DNA was removed from the RNA by treating 1 g total RNA with 1 U DNase according to the manufacturer's recommendation (Ambion). First-strand cDNA was generated from 1 g total RNA using random hexamers and reverse transcription reagents (TaqMan; PE Biosystems, Foster City, CA) according to the manufacturer's instructions. cDNA was diluted to a working concentration of 0.5 ng/L in water containing 50 g/mL glycogen (Gly-FIGURE 1. Comparison of human TGF␤2 amino acid sequence (NP_ 003229) with that of monkey TGF␤1 (XP_512687), 37 pig TGF␤1 (NP_ 999180), 38 human TGF␤1 (P01137), 39 cow TGF␤1 (P18341), 40 rat TGF␤1 (NP_067589), 41 mouse TGF␤1 (NP_ 035707), 42 and mouse TGF␤2 (NP_ 033393). 42 Gray: identical amino acids. Asterisk: cysteine residues targeted for mutation to serine. coBlue; Ambion). Effective removal of contaminating adenoviral DNA was verified in control reactions minus reverse transcriptase.
Quantitative PCR
Transcript levels were measured by quantitative RT-PCR (QRT-PCR) using a sequence detection system (ABI Prism 7700; Applied Biosystems, Foster City, CA) essentially as described. 46 Primers (TaqMan; Applied Biosystems) for hCTGF (Hs00170014_m1; 47 ), mCTGF (Mm00515790_g1), hPAI-1 (Hs00167155_m1), hCOL1A1 (Hs00164004_m1), hTGF␤2 (Hs00234244_ m1), mCOL4A1 (Mm00802377_m1), mPAI-1 (Mm00435860_m1), and mNOX4 (Mm00479246_m1) were purchased. Primer/probe for the EDA splice variant of human fibronectin (NM_002026, exon 32) was generated (Assay By Design; Applied Biosystems): CCTACTCGAGCCCTGAG-GAT (forward), FAM-AATCCATGAGCTATTCCC-MGBNFQ (probe), and TGCAGTGTCTTCTTCACCATCAG (reverse). Amplification of all target gene mRNA was normalized to 18S ribosomal RNA expression using primers designed to the 18S rRNA gene (GenBank accession no. X03205) GTCCCTGCCCTTTGTACACAC (forward), VIC-CGCCCGTC-GCTAC-MGBNFQ (probe), and CGATCCGAGGGCCTCACTA (reverse). Quantification of relative RNA concentrations was made using the comparative Ct method, as described in PE Biosystems User Bulletin 2 (http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf).
Determination of TGF␤2 Protein by ELISA
TGF␤2 concentrations were determined in aqueous humor or cell culture medium using a human TGF␤2 ELISA kit (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions. Total TGF␤2 levels were determined by acid-activation of samples. 
Histology
Eyes were removed and fixed for 24 hours in 4% paraformaldehyde and embedded in paraffin wax for sectioning. Sections (5 m) were stained with hematoxylin and eosin reagent.
Rebound Tonometer Calibration
Uninjected and hTGF␤2 226/228 -expressing eyes were cannulated intracamerally with a 30-gauge steel needle and connected by flexible tubing to a variable-height physiologic saline manometer. Incorporated in series within the tubing was a previously calibrated (sphygmomanometer) pressure transducer (BLPR-2; World Precision Instruments, Sarasota, FL) for the continuous monitoring of actual (manometric) pressure. In this way pressure in the system could be set (10 -40 mm Hg in increments of 5 mm Hg) and recorded. Ten tonometer (TonoLab; Colonial Medical Supply) readings were taken against each eye at each pressure, and then tonometer-indicated pressure was plotted as ordinate against manometrically set pressure as abscissa. A simple linear regression was performed on each curve (Prism 5; GraphPad Software, San Diego, CA).
Aqueous Humor Hydrodynamics
For aqueous humor dynamics assessment, animals were anesthetized with intraperitoneal injection of an anesthetic cocktail (ketamine [72.7 mg/kg, Fort Dodge Animal Health], xylazine [1.8 mg/kg Vetus; Burns Veterinary Supply], and acepromazine [1.8 mg/kg Vetus; Burns Veterinary Supply]). Maintenance doses of the anesthetic cocktail (onequarter to one-half the initial dose) were given subsequently as required. Each animal was then placed on a heated pad (37°C) for maintenance of body temperature and left for 30 minutes to allow a plane of surgical anesthesia to develop, judged to be of sufficient depth when the animal failed to react to toe-pinch (absence of flexor withdrawal response) and the blink reflex was absent. One to two drops of 0.5% proparacaine HCl (Alcaine; Alcon Research, Ltd.) were then applied (topical ocular) to each eye for local anesthesia. The eyes were then cannulated intracamerally with a 30-gauge steel needle inserted through the peripheral cornea approximately 1 to 2 mm from the limbus and pushed toward the region of the opposing chamber angle, taking care not to strike the corneal endothelium, anterior surface of the iris, anterior lens capsule, or chamber angle itself. The needle was connected by tubing to an in-line pressure transducer (BLPR; World Precision Instruments) for the continuous determination of pressure within the system. The opposing terminal of the pressure transducer was connected by tubing to a 3-mL syringe loaded into a microdialysis infusion pump (SP101I Syringe Pump; World Precision Instruments). The pump was then switched on and set to a flow rate of 0.1 L/min. The pump remained running until the pressure (which was continuously recorded) in the system stabilized (typically 10 -15 minutes). Flow rate was then increased sequentially to 0.2 and 0.3 L/min, and stabilized pressure values at each flow rate were recorded. For each eye, aqueous humor outflow facility (L/min/mm Hg) was calculated as the reciprocal of the slope of the respective pressure-flow rate curves.
Statistical Analysis
Data are presented as mean Ϯ SEM. The Student's t-test was used to compare between two groups of results. One-way ANOVA followed by Dunnett's test was used to compare among three or more groups. 
RESULTS
In Vitro Characterization of TGF␤2 Constructs
Our initial attempt to produce elevated levels of active human TGF␤2 in the rodent eyes used adenovirus (Ad5) to drive the expression of full-length, wild-type hTGF␤2 (Ad.hTGF␤2 WT ). Subsequently, we developed an adenovirus expressing fulllength hTGF␤2 with two point mutations incorporated into the LAP-binding portion (C226S, C228S) (Ad.hTGF␤2 226/228 ), as described previously for the TGF␤1 isoforms in monkey, 37 pig, 38 human, 39, 48 bovine, 40 rat, 41 and mouse 42 and the TGF␤2 isoform in the mouse 42 ( Fig. 1) . To verify the vector-mediated expression of TGF␤2, we transfected CHO cells ( Fig. 2A) . After 48 hours, culture medium was analyzed by ELISA for active and total (active plus latent) TGF␤2. Total TGF␤2 was determined by acidification of the samples, which converts latent molecules to active molecules. In both cell types, the level of active TGF␤2 produced by the hTGF␤2 226/228 vector was approximately 5 ng/mL (Fig. 2) . Total TGF␤2 levels were twofold higher in p.hTGF␤2 226/228 -than in p.hTGF␤2 WT -transfected CHO cells, and the level of active TGF␤2 accounted for 25% of total TGF␤2 in the p.hTGF␤2 226/228 transfected cells compared with 8% in the p.hTGF␤2
WT -transfected cells ( Fig.  2A) . In the GTM3 cells, total TGF␤2 levels were 10-fold higher in the Ad.TGF␤2
226/228 -than in the Ad.TGF␤2 WT -transduced cells, and the level of active TGF␤2 was 31% of total TGF␤2 in the Ad.TGF␤2
226/228 -transduced cells compared with 13% in the Ad.hTGF␤2
WT -transduced cells (Fig. 2B) . The biological activity of Ad.hTGF␤2
WT and Ad.hTGF␤2 226/228 was determined by QRT-PCR analyses of downstream effectors of TGF␤2 in TM cells, 28 such as connective tissue growth factor (CTGF), plasminogen activator inhibitor-1 (PAI-1), the EDA splice variant of fibronectin (FN-EDA), and collagen 1A1 (COL1A1) (Fig. 3) . CTGF and PAI-1 were significantly (P Ͻ 0.01) induced by Ad.hTGF␤2 226/228 but not by Ad.hTGF␤2
WT or control Ad.Empty viruses (Fig. 3) . COL1A1 was less respon-sive but still significantly induced by both Ad.hTGF␤2 WT (P Ͻ 0.05) and Ad.hTGF␤2 226/228 (P Ͻ 0.01) (Fig. 3) 226/228 in the rats significantly increased IOP 5 to 12 days after injection (Fig. 4A) . In the Ad.hTGF␤2 226/228 -injected eyes, IOP at day 7 equaled 25.4 Ϯ 2.4 mm Hg (mean Ϯ SEM, n ϭ 7), which was statistically significantly different (P Ͻ 0.001) from that of the noninjected eyes (17.8 Ϯ 0.2 mm Hg; n ϭ 14). Ad.Empty injection did not affect IOP (18.5 Ϯ 0.6 mm Hg; n ϭ 7; P Ͼ 0.05). Ad.hTGF␤2
226/228 -induced ocular hypertension lasted for up to 8 days, after which the IOP declined toward the baseline value.
The effect of Ad.hTGF␤2 226/228 was also tested in the mouse. Previously, we found that expression of adenovirus in the anterior segment of the mouse eye was more efficient when the vector was injected intravitreally. 16 Hence, Ad.hTGF␤2
226/228 (6 ϫ 10 7 pfu) was administered intravitreally in BALB/cJ mice. Significantly elevated IOP occurred starting at day 4 after injection and reached a plateau from days 6 to 15 (Fig. 4B) . IOP at day 6 was 26.1 Ϯ 4.0 mm Hg (n ϭ 6) in the Ad.hTGF␤2
226/228 -injected eyes, significantly different (P Ͻ 0.001) from the noninjected group (12.4 Ϯ 0.9 mm Hg; n ϭ 12). After day 15, Ad.hTGF␤2 226/228 -induced ocular hypertension slowly declined, but at day 29 the IOP in these eyes was still statistically higher (P Ͻ 0.05) than in the noninjected eyes. Similar to results seen in the rat, intraocular injection of Ad.Empty did not affect IOP (day 6 IOP, 12.0 Ϯ 0.3 mm Hg; n ϭ 6).
In a separate group of animals, evaluation of tissues from anterior segments of mouse eyes at day 8 after injection revealed a significant correlation (r ϭ 0.88; P Ͻ 0.0001) between IOP (measured at day 7) and virally expressed TGF␤2 transcript levels (Fig. 5A ). In the uninjected eyes (n ϭ 6), there was no detectable transcript level of TGF␤2. Only the Ad.hTGF␤2 226/228 -injected eyes (n ϭ 6) had measurable levels (Fig. 5A) . In this study, aqueous humor was collected from mouse eyes on day 14 after injection, pooled and analyzed by ELISA for total TGF␤2 levels. Correspondingly, aqueous humor TGF␤2 levels were significantly (P Ͻ 0.01) elevated in Ad.hTGF␤2 226/228 -injected eyes (1.58 Ϯ 0.06 ng/mL) versus uninjected eyes (0.46 Ϯ 0.14 ng/mL) (Fig. 5B) . In addition, when anterior segment tissue from mouse eyes was examined for marker gene expression after Ad.hTGF␤2 226/228 injection, endogenous mouse CTGF, PAI-1, and NADPH oxidase 4 (NOX4) levels were significantly (P Ͻ 0.05) elevated in Ad.hTGF␤2 226/228 -treated versus uninjected eyes, whereas COL4A1 levels were not significantly altered (Fig. 6 ). WT or Ad.hTGF␤2 226/228 (n ϭ 3). Samples were collected 48 hours after transfection or transduction and assayed for hTGF␤2 by ELISA. Results are expressed as mean Ϯ SEM (n ϭ 3). **P Ͻ 0.01 or ***P Ͻ 0.001 compared with the respective empty vector group by one-way ANOVA and then Dunnett's test.
Expression (Normalized to 18S)
Mouse Eye Histology
Morphologic analysis of the adenovirus-injected mouse eyes showed that compared with control eyes (Figs. 7A, 7B ), adenoviral (Ad.Empty) injection alone (Figs. 7C, 7D ) caused increased overall corneal thickness, modest anterior chamber inflammation, and a propensity toward juxtaposition of the corneal endothelium to the iris during tissue sectioning, yet showed no signs of decreased lenticular or corneal transparency or elevated IOP. Similar morphologic changes have been noted by others using either AdTGF␤1 or Ad.Empty-injected mouse eyes. 50 On the other hand, Ad.hTGF␤2 226/228 -injected eyes (Figs. 7E, 7F ) appeared similar in morphology to Ad.Empty-injected eyes, yet had elevated IOP that was not seen with Ad.Empty eyes or previously with either Ad.GFP-or Ad.MYOC WT -injected eyes. 16, 51 It is also noteworthy that Ad.hTGF␤2 WT -injected eyes had similar histologic changes yet did not develop elevated IOP, further supporting the requirement for expression of active TGF␤2 from the adenovirus for elevated IOP.
Rebound Tonometer Calibration
To assess whether the impact of tonometry against corneas of both uninjected eyes and eyes expressing hTGF␤2 226/228 was yielding accurate and reproducible readings of IOP, we compared IOP readings from cannulation with those from the tonometer (TonoLab; Tiolat Oy) for an uninjected eye with an IOP of 12.4 Ϯ 0.3 mm Hg and paired hTGF␤2 226/228 -expressing eye with an IOP of 25.9 Ϯ 0.4 mm Hg (Fig. 8) . The tonometer (TonoLab; Tiolat Oy)-generated IOP readings correlated well with the actual IOP in either the uninjected (r 2 ϭ 0.98) or the hTGF␤2 226/228 -expressing (r 2 ϭ 0.99) eyes. The rebound tonometer (TonoLab; Tiolat Oy) yielded a reading ϳ9% less than the actual manometric pressure with the uninjected eye over the range 10 to 40 mm Hg (Fig. 8A) . When tested against the hTGF␤2-expressing eye over the same pressure range, there was a slightly greater degree of accuracy inherent within the IOP readings, but readings were still ϳ16% greater than the actual manometric pressure (Fig. 8B) . Thus, although overex- pression of hTGF␤2 caused thickening of the cornea, the tonometer readings provided an acceptable degree of accuracy and reproducibility.
Aqueous Humor Hydrodynamics
To evaluate the effect of hTGF␤2 on aqueous humor outflow rate, one eye each of six mice was injected intravitreally with Ad.hTGF␤2 226/228 , and 5 to 7 days later aqueous outflow facility was determined in both eyes. IOP of conscious animals immediately before outflow facility determination was 24.3 Ϯ 2.2 mm Hg in the Ad.hTGF␤2
226/228 -injected eyes and 11.4 Ϯ 0.5 mm Hg (P Ͻ 0.001) in the contralateral uninjected eyes. When the eyes of the anesthetized mice were infused with balanced salt solution (BSS Plus; Alcon) at various flow rates, a resultant change in IOP was observed (Fig. 9A) . The IOP of control mouse eyes correlated linearly with the infusion rate (r 2 ϭ 0.994). The mean regression slope of these eyes was 76.6 Ϯ 9.6 mm Hg/L/min. Similarly, the flow rate-IOP relationship of the Ad.hTGF␤2
226/228 -injected eyes was also linear (r 2 ϭ 0.994) with a mean regression slope of 134.1 Ϯ 28.3 mm Hg/L/min, which is statistically significantly different from the control uninjected eyes (P Ͻ 0.05; paired Student's t-test).
mRNA Expression (% Control) The AH outflow facility calculated from the inverse of the regression slope of the vector-treated eyes was 0.0098 Ϯ 0.0023 L/min/mm Hg, which is significantly (P Ͻ 0.01) lower than that of the control uninjected eyes (0.0146 Ϯ 0.0024 L/min/mm Hg) (Fig. 9B) . These data indicate that Ad.hTGF␤2 226/228 treatment increased mouse IOP by, at least in part, reducing AH outflow facility. These in vivo data are consistent with our previous report of TGF␤2 effects on perfusion cultured anterior segments. 28 Perfusion was performed at constant flow, so the TGF␤2 increase in IOP was exclusively due to a decrease in the aqueous outflow facility.
DISCUSSION
In this study, we have demonstrated that transfection of CHO and transduction of GTM-3 cells with vectors expressing either hTGF␤2 WT or hTGF␤2 226/228 , but not control vectors, increased the expression of total and active human TGF␤2 levels. The effect of Ad.hTGF␤2 226/228 , especially on active TGF␤2 expression, was significantly more prominent than that of Ad.hTGF␤2
WT . Previous reports have shown that cells treated with active TGF␤ can undergo autoinduction of TGF␤ gene synthesis 52 and have increased expression of TGF␤-converting enzyme furin. 53 Chagraoui et al. 54 showed that mice transduced with adenovirus-expressed monkey TGF␤1 223/225 had high levels of TGF␤1 because of autocrine production by the exogenous bioactive TGF␤1. These authors used TGF␤1 knockout embryonic fibroblasts to show that the effect was autostimulatory. The overexpression of active TGF␤2 in our cells correlated with increased downstream effector molecules known to be involved in the TGF␤2-signaling pathways, such as CTGF, PAI-1, and COL1A1, indicating that the cytokine was biologically functional. The amount of activated human TGF␤2 226/228 detected in our in vitro assays was within the range found for similar orthologous TGF␤ bioactive mutations. 37,38,54 -56 The mutations introduced into hTGF␤2 only make the molecule more susceptible to furin-protease cleavage; therefore, production of the active form is not expected to be quantitative.
Intraocular injection of Ad.hTGF␤2 226/228 , but not Ad.hTGF␤2
WT or Ad.Empty, induced ocular hypertension in the rat and mouse. The lack of effect of Ad.hTGF␤2
WT suggests that rodent eyes have sufficient regulatory mechanisms in place to prevent the activation of exogenous TGF␤. In this sense, Ad.hTGF␤2
WT served as an effective negative control. In the rat, Ad.hTGF␤2 226/228 increased IOP by 43% at day 7 after treatment, whereas intravitreal injection of the vector elevated mouse IOP by 110% at day 6. This TGF␤2-induced pressure elevation was concomitant with an increase in TGF␤2 levels in the AH and enhanced the expression of signaling molecules downstream of TGF␤2 activation, such as CTGF, PAI-1, and NOX4 in the anterior segment of the eye. Any differences in TGF␤2-response genes between our current and previous 28 studies may be attributed to differences in the experimental setup and treatment timing. Previous work by our laboratory using intravitreal injection of Ad.GFP (with a titer similar to that of the present study) detected gene expression in the trabecular meshwork and corneal endothelium and sporadically in iris, ciliary body, and lens epithelium. 16 Based on the similarities of the adenoviral vectors, we presumed that the localization of TGF␤2 expression in our present study was similar. This assumption was corroborated by the increased expression of TGF␤2 in the anterior segments of the mouse and elevated levels of TGF␤2 in the aqueous humor. Furthermore, within each mouse, the extent of IOP increase correlated with the ocular level of TGF␤2 mRNA. Thus, the ocular hypertensive effect and corresponding changes support the role of TGF␤2 in the glaucoma phenotype.
Elevation of IOP can be generated, in theory, by an increase in AH production or a reduction of AH outflow facility, by an increase in episcleral venous pressure, by a reduction in uveoscleral outflow, or by some combination of these factors. In patients with POAG, experimental evidence indicates that pathologically impaired AH outflow facility is the mechanism for elevated IOP. Similarly, the IOP increase induced by Ad.hTGF␤2 226/228 treatment was, at least in part, a result of the impaired AH outflow facility. To evaluate the effect of TGF␤2 on aqueous humor hydrodynamics in the mouse eye, we developed a constant flow infusion method modified from that reported by Aihara et al. 57 The validity of this method was confirmed by its detection of the outflow-enhancing effect of latanoprost, a prostaglandin agonist, and the lack of outflow effect of betaxolol, a ␤-adrenergic antagonist (Millar JC, et al. These results are, as expected, based on the known mechanism of action of these glaucoma therapeutic agents. 58 Using this constant flow technique, we showed that mouse eyes injected with Ad.hTGF␤2 226/228 had a suppressed AH outflow facility at each of the infusion flow rates tested. The biochemical and morphologic changes responsible for this observation are not understood but were likely a result of altered biochemical and physical properties, such as elasticity, compressibility, and response to shear stress, of structures in the outflow pathway in response to the overexpression of active TGF␤2. Because TGF␤2 is known to modify ECM production and metabolism in the TM, we speculate that TGF␤2-induced ECM changes caused such abnormality. However, the involvement of other possibilities, such as TGF␤2-altered expression of various other cytokines and signaling molecules, which further affect cytoskeleton and other cell and tissue functions, cannot be excluded. A recent report using intracameral delivery of adenovirus-expressing active TGF␤1 in male Wistar rat eyes showed morphologic changes that the authors described as peripheral anterior synechiae. 59 These authors have also previously reported anterior subcapsular cataract in C57Bl/6 mice. 50 Any differences between their studies and ours may be attributed to the choice of delivery route, cytokine (TGFB1 vs. TGFB2) and species/strain. Because our model involves transient elevation of TGF␤2 in adult mice eyes, we did not see, and did not expect to see, some of the severe changes in ocular tissues noted with transgenic mice engineered to chronically overexpress active TGF␤1 in a lens-specific manner. 39, 60, 61 However, we did see an effect of adenovirus injection alone on anterior segment morphology, but these effects were independent of IOP elevation. Further, data obtained during the tonometer (TonoLab; Colonial Medical, Franconia, NH) calibration studies with both uninjected and hTGF␤2-expressing eyes confirmed that tonometry was accurate and reproducible regardless of corneal morphology. An ex vivo outflow model with human eyes (isolated and independent of the immune system and blood circulation) perfused continuously with human recombinant TGF␤2 showed decreased outflow facility and increased extracellular matrix material, 28, 31 which is consistent with our in vivo results using adenoviral overexpressed TGF␤2. Altogether, our data support the hypothesis that adenovirusmediated expression of TGF␤2 226/228 in the anterior segment of the mouse eye is the basis for elevated IOP.
In this study, the adenovirus-mediated gene expression in the rodent eye was transient, which is consistent with previously published reports using adenovirus in the rodent eye. 16, 62, 63 The Ad.hTGF␤2 226/228 -elevated IOP started to return to baseline IOP at approximately day 8 in the rat and day 18 in the mouse. This short-lived expression most likely was a result of immune responses generated by the host animal against viral proteins. [63] [64] [65] Recently, with the use of green fluorescent protein as a reporter transgene, we showed that immunomodulation achieved by treating the animals with an anti-CD40L antibody, which specifically suppresses the CD4 ϩ T-cell-assisted, but not B-cell-mediated, humoral responses normally mounted against adenovirus can significantly lengthen the duration of adenoviral transgene expression in the mouse eye. 16 Ongoing studies in our laboratory indicate that ocular hypertension induced by Ad.hTGF␤2 226/228 can be prolonged by anti-CD40L antibody treatment to at least 150 days.
The use of adenoviral vectors to induce gene expression in tissues of the anterior segment, such as the TM, is a significant achievement in glaucoma research. Adenovirus is one of the most popular techniques to introduce genes into the TM of different animals. 34,62,63,66 -68 With this method, genes such as myocilin 16 and secreted frizzled-related protein 51 have been shown to contribute to the regulation of IOP and the potential pathogenesis of glaucoma. Besides adenovirus, other methods for delivering genes to the anterior segment of the eye include liposomes, 69 adenoassociated virus (AAV), 70 herpes simplex viral vectors, 71 and lentivirus. 72, 73 Like adenovirus, each method has distinct advantages and disadvantages, but AAV and lentivirus appear to offer the hope of sustained expression of the delivered gene product. In the future, it would be useful to explore the use of AAV or lentivirus to deliver hTGF␤2 226/228 for sustained expression of TGF␤2 and the potential development of glaucomatous optic neuropathy and retinopathy in an animal model.
In conclusion, we have developed a rodent model that displays the glaucoma risk factors of elevated IOP and decreased aqueous outflow caused by the overexpression of active, but not latent, TGF␤2. Our model may be useful for the further study of POAG mechanism, development, and progression.
